Wordt geladen...
The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy
Years of tremendous study have dawned a new era for the treatment of cystic fibrosis (CF). For years CF care was rooted in the management of organ dysfunction resulting from the mal-effects of absent anion transport through the CF transmembrane regulator (CFTR) protein. CFTR, an adenosine triphospha...
Bewaard in:
| Gepubliceerd in: | Ther Adv Respir Dis |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6487765/ https://ncbi.nlm.nih.gov/pubmed/31027466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466619844424 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|